ST LEONARDS PRACTICE — All Prescriptions & Medications — Page 10

Practice Code: L83042 | EXETER, EX1 1SB

Showing results 451-500 of 611

MedicationItems (12m) ↓QuantityCostvs National
Terbinafine hydrochloride25570£104-32.6% ▼
25690£1.6K-23.3% ▼
25140£288+112.0% ▲
25550£1.8K-18.6% ▼
25195£313+51.5% ▲
25880£502-14.9% ▼
Salmeterol2424£672-0.2% vs avg
Chlorhexidine gluconate2416.3K£288-18.7% ▼
24185£379+64.3% ▲
Theophylline231,680£850-72.5% ▼
RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011)2358.0K£992-39.7% ▼
Acetylcysteine23230£1.8K+127.0% ▲
Carmellose sodium231,920£276-64.5% ▼
232,400£394-15.8% ▼
Sodium picosulfate226,600£610-39.4% ▼
Goserelin acetate2222£2.4K-50.1% ▼
Menthol226,700£248-21.9% ▼
Adapalene22990£344+0.5% vs avg
Amorolfine hydrochloride22130£164-4.7% ▼
226,879£169-55.9% ▼
22280£183-49.0% ▼
22220£690+8.1% ▲
22810£1.8K+55.5% ▲
Amiloride hydrochloride211,008£492-16.6% ▼
Colestyramine211,818£948-27.1% ▼
Hydroxyzine hydrochloride21777£25-60.6% ▼
Levomepromazine maleate21406£108+128.7% ▲
RtS 1.5 - 1.6 kcal/ml milkshake with fibre (0913011)2172.8K£1.1K+58.0% ▲
Mupirocin2172£97+78.9% ▲
21660£1.1K+188.2% ▲
211,430£4.9K-6.3% ▼
Valsartan20644£155-66.0% ▼
Sulpiride20952£80-25.3% ▼
Pizotifen malate201,046£47-75.7% ▼
Phenobarbital201,484£44-35.0% ▼
Cocois203,240£487+45.7% ▲
202,940£510+14.6% ▲
Glycopyrronium bromide192,958£6.7K-7.5% ▼
Glycerol19272£44-45.8% ▼
RtS 2 kcal/ml m/sk high protein, high energy+fibre (0913011)1930.4K£370+59.4% ▲
Brinzolamide and timolol19190£399-49.7% ▼
Light liquid paraffin1912.0K£225-44.2% ▼
19256£648+21.1% ▲
19267£259+91.6% ▲
19680£3.3K-26.5% ▼
19500£1.5K+1.8% vs avg
Telmisartan18588£82-69.0% ▼
Codeine phosphate183,600£126+25.4% ▲
Clomipramine hydrochloride181,736£260-57.3% ▼
Biphasic isophane insulin18145£572-83.9% ▼
← Back to ST LEONARDS PRACTICE
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.